Evidence map›Paper›PMID 42271276›Full record

ArticleBMC geriatrics2026

Admission creatinine and outcomes in very elderly critically ill patients: a retrospective cohort study.

Alexandre Klopp, Silvia de Rosa, Elisa Alba Schmidt, Markus Haar, Anna Carola Hertrich, Christina Thompson, Rikus Daniels, Pauline Theile, Markus Goedel, Stefan Kluge and 4 more

Abstract read
In one paragraph

Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Alexandre KloppIII. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. a.klopp@uke.de.
Silvia de RosaCentre for Medical Sciences - CISMed, University of Trento, Trento, Italy.
Elisa Alba SchmidtIII. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Markus HaarDepartment of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Anna Carola HertrichDepartment of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Christina ThompsonIII. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Rikus DanielsDepartment of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Pauline TheileDepartment of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Markus GoedelDepartment of Geriatrics, Albertinen Hospital, Hamburg, Germany.
Stefan KlugeDepartment of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Tobias B HuberIII. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Jakob MüllerDepartment of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Kevin Roedl *Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Christian Schmidt-Lauber *III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSerum creatinine at ICU admission is a central component of prognostic assessment in critically ill patients and is widely used as a marker of kidney function in clinical practice, as well as being incorporated into established prediction models. However, in very old patients, age-related muscle loss, frailty, and altered creatinine kinetics may limit its validity. With ICU admissions among nonagenarians (≥ 90 years) steadily increasing, it remains unclear whether admission creatinine retains its prognostic relevance in this population. We therefore evaluated the prognostic value of admission creatinine for short- and long-term outcomes in critically ill nonagenarians and assessed its role within the SOFA score.

methodsThis retrospective cohort study included all patients aged ≥ 90 years admitted to the ICUs of the University Medical Center Hamburg-Eppendorf between 2008-2019. Admission serum creatinine was analyzed as the primary exposure variable. Primary outcomes were in-hospital, 90-day, and 1-year mortality. Associations between admission creatinine and outcomes were analyzed using logistic and Cox regression models adjusted for relevant confounders. To evaluate the prognostic contribution of kidney function to established risk scores, we compared the predictive performance of the full SOFA score with a modified SOFA score excluding the kidney (creatinine) component.

resultsAmong 952 patients (median age 92.2 years) in-hospital, 90-day, and 1-year mortality rates were 28.5%, 42.2%, and 57.1%, respectively. Admission creatinine was not independently associated with in-hospital mortality (adjusted hazard ratio [HR] 1.07, 95% CI 0.92-1.26). In contrast, higher admission creatinine independently predicted 90-day mortality (adjusted HR 1.16, 95% CI 1.01-1.34) and 1-year mortality (adjusted HR 1.20, 95% CI 1.06-1.36). The Full and non-kidney SOFA scores performed similarly (AUC 0.79 each).

conclusionsIn critically ill patients aged ≥ 90 years, admission creatinine does not independently predict short-term outcomes but remains a robust predictor of mid- and long-term mortality. The unchanged performance of the SOFA score after removal of its kidney component underscores the limited relevance of creatinine for short-term risk stratification in this age group and supports age-adapted interpretation of kidney biomarkers and prognostic models in very old ICU patients.

Indexed as

CreatinineCritical IllnessPatient AdmissionAged, 80 and overBiomarkersCohort StudiesFemaleHospital MortalityHumansIntensive Care UnitsMalePrognosisRetrospective StudiesBiomarkersCreatinineAcute kidney injuryCreatinineIntensive care unitKidney functionNonagenariansVery elderly patients

Identifiers

PMID42271276
PMCPMC13255386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.